‘Impenetrable medical jargon’: Why retooling ClinicalTrials.gov should be a priority

clinical trial finder custom@ x
Credit: Health Union

Millions of people visit ClinicalTrials.gov each year to find a trial that they or a loved one might be eligible to join. It’s the largest public database of clinical studies in the world, listing more than 300,000 trials in the U.S. and around the world.

But as patients, families, and advocacy groups all say, ClinicalTrials.gov is not an easy website to use. Trial designs are confusing to users who aren’t familiar with clinical research. And inclusion and exclusion criteria, as well as outcome measures, often read as impenetrable medical jargon that only researchers can understand.

The best option would be for all trial seekers to use a retooled ClinicalTrials.gov that could quickly and easily allow them to restrict their searches to a particular geographic area, a single institution, or a disease type, rather than relying upon a patchwork of trial finders.

Related article:  Viewpoint: Study's inability to find a 'gay gene' provides affirmation for LGBTQ community
[O]ther trial finders show only trials that are recruiting or that haven’t yet begun recruiting, instead of including past, present, and future trials in their results. After all, if you’re a patient looking for a trial to participate in, you aren’t interested in ones that have already closed.

The move to modernize ClinicalTrials.gov is a unique opportunity to create one premier trial-finding site. Let’s make sure it gets done right.

Read the original post

Outbreak Daily Digest
Biotech Facts & Fallacies
Genetics Unzipped
Infographic: How dangerous COVID mutant strains develop

Infographic: How dangerous COVID mutant strains develop

Sometime in 2019, probably in China, SARS CoV-2 figured out a way to interact with a specific "spike" on the ...

Philip Njemanze: Leading African anti-GMO activist claims Gates Foundation destroying Nigeria

Nigerian anti-GMO activist, physician, and inventor pushes anti-gay and anti-GMO ...
News on human & agricultural genetics and biotechnology delivered to your inbox.
glp menu logo outlined

Newsletter Subscription

Optional. Mail on special occasions.
Send this to a friend